Actavis in Europe
Actavis maintains modern, state-of-the-art development and manufacturing facilities throughout Europe, including Iceland, Northern Ireland, UK, Italy, Malta, Netherlands, Greece, Bulgaria, Romania, Serbia and Russia. These facilities produce a range of medicines in various formulations, including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids. Additionally, the Company has biosimilars capabilities in the UK.
Actavis’ European commercial offices are located in Austria, France, Germany, the Netherlands, Nordic region, Portugal, Switzerland, UK, Ireland, the Balkan region, the Baltic region, Belarus, Bulgaria, the Commonwealth of Independent States (CIS), the Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, Turkey, and Ukraine.